Tuesday, August 10, 2021 9:36:35 PM
American Brain Tumor Email about NWBO I sent an email to them early today, below is what I ask and the response: I will be posting on Twitter as well.
Dear xxxxx,
Thank you for your interest in our upcoming National Conference. Northwest Biotherapeutics will have a brief session during the event titled "Accelerating the Pathways for New Treatments". This will occur on Saturday, September 11 at 12pm CT during the lunch break.
Please let me know if you have any questions. We hope that you are able to attend and gain benefit from the program.
Wishing you the best,
Ambreen
- How did we do? Take our 2-minute CareLine Survey
From: xxxxxxxxxxxxxxxxxxxxxxxxxx
Sent: Tuesday, August 10, 2021 12:13 PM
To: info@abtacares@ABTA <info@abta.org>
Subject: Sponsorship / Presentatios
Hello
Noticed one of your sponsors is Northwest Biotherapeutics, are they are doing any presentations at your event?
Thank you
--
Dear xxxxx,
Thank you for your interest in our upcoming National Conference. Northwest Biotherapeutics will have a brief session during the event titled "Accelerating the Pathways for New Treatments". This will occur on Saturday, September 11 at 12pm CT during the lunch break.
Please let me know if you have any questions. We hope that you are able to attend and gain benefit from the program.
Wishing you the best,
Ambreen
- How did we do? Take our 2-minute CareLine Survey
From: xxxxxxxxxxxxxxxxxxxxxxxxxx
Sent: Tuesday, August 10, 2021 12:13 PM
To: info@abtacares@ABTA <info@abta.org>
Subject: Sponsorship / Presentatios
Hello
Noticed one of your sponsors is Northwest Biotherapeutics, are they are doing any presentations at your event?
Thank you
--
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
